
The Case for Combined‐Modality Therapy for Limited‐Stage Hodgkin's Disease
Author(s) -
HillKayser Christine E.,
Plastaras John P.,
Tochner Zelig,
Glatstein Eli
Publication year - 2012
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2012-0148
Subject(s) - medicine , disease , stage (stratigraphy) , radiation therapy , modality (human–computer interaction) , treatment modality , oncology , surgery , paleontology , human–computer interaction , computer science , biology
Results of the Hodgkin's Disease.6 trial are critically examined in light of the advances in radiation therapy techniques that have occurred since it was initiated. The ultimate findings of the HD.6 trial do not close the case for combined‐modality treatment of limited‐stage Hodgkin's disease.